H. Lundbeck A/S

                   

Lundbeck Starts Clinical Phase IIa With Lu AA24493 (cEPO) In Friedreich's Ataxia In A Study Also...

medicalnewstoday.com
Nov 7, 2009
 

H. Lundbeck A/S strengthens its pipeline of pharmaceuticals in clinical development by initiating phase IIa clinical studies with the innovative project Lu AA24493 in order to evaluate safety and tolerability and to explore...

powered by

Lundbeck starts clinical phase IIa with Lu AA24493 (cEPO) in Friedreich's ataxia

bionity.com
Nov 3, 2009 5 related
 

03 Nov 2009 - H. Lundbeck A/S strengthens its pipeline of pharmaceuticals in clinical development by initiating phase IIa clinical studies with the innovative project Lu AA24493 in order to evaluate safety and tolerability and...

powered by

Lundbeck - Third quarter 2009 report - Lundbeck records 20% growth, driven by Lundbeck Inc. and...

ad-hoc-news.de
Nov 3, 2009 2 related
 

Lundbeck Inc. reports third quarter revenue of DKK 359 million. H. Lundbeck A/S (Lundbeck) reports third quarter revenue of DKK 3,264 million growing 20% in constant exchange rates compared to the third quarter of 2008. Revenue...

powered by

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development...

bionity.com
Nov 2, 2009
 

02 Nov 2009 - H. Lundbeck A/S strengthens its pipeline of pharmaceuticals in clinical development by initiating phase I clinical studies with Lu 02-750 in order to investigate safety, tolerability and the pharmacokinetic...

powered by
                   

Lundbeck commended for climate change disclosure

pharmiweb.co.uk
Oct 28, 2009 8 related
 

Lundbeck has been commended for its approach to climate change disclosure by the Carbon Disclosure Project (CDP), which represents 475 institutional investors with $55 trillion in assets under management. For the first time H....

powered by
                   

Lundbeck Honored with the Marjorie Guthrie Leadership Award for Ongoing Commitment to the...

redorbit.com
Oct 9, 2009 3 related
 

Posted on: Friday, 9 October 2009, 08:00 CDT DEERFIELD, Ill., Oct. 9 /PRNewswire/ -- The Huntington's Disease Society of America (HDSA) recognized Lundbeck last night with the Marjorie Guthrie Leadership Award for the company's...

powered by

Component Changes Made To Dow Jones STOXX Indexes

exchange-handbook.co.uk
Oct 7, 2009 4 related
 

STOXX Ltd., the leading provider of European equity indexes, today announced changes in several Dow Jones STOXX indexes. Birmingham City PLC (U.K., Travel & Leisure, BMC.LN) will be removed from the Dow Jones STOXX Football...

powered by

Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest...

comparenetworks.com
Oct 5, 2009 3 related
 

Caraco Pharmaceutical Laboratories, Ltd. announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro® (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA")...

powered by
                   

Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest...

redorbit.com
Oct 2, 2009 16 related
 

Posted on: Friday, 2 October 2009, 08:05 CDT DETROIT, Oct. 2 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the previously announced settlement of the legal...

powered by
                   

National Association of Neonatal Nurses & Lundbeck Inc. announce scholarship recipients

genengnews.com
Sep 25, 2009 3 related
 

EUREKALERT Contact: Nikki Kidd nikki.kidd@edelman.com Two nurses awarded Lundbeck Neonatal Nursing Career Path scholarships today GLENVIEW, Ill., September 25, 2009 The National Association of Neonatal Nurses (NANN) is proud to...

powered by
1 2 3 4 5 next »